106 related articles for article (PubMed ID: 27628554)
1. [Outcomes of Staging Laparoscopy in Eight Patients with Positive Peritoneal Washing Cytology after S-1 Administration].
Suzuki K; Yajima K; Iwasaki Y; Yuu K; Oohinata R; Amaki M
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1109-12. PubMed ID: 27628554
[TBL] [Abstract][Full Text] [Related]
2. [A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
Yamamura A; Ono F; Hiraga M; Omura N; Takano N; Sato H; Toyama S; Onochi S
Gan To Kagaku Ryoho; 2014 Jun; 41(6):773-5. PubMed ID: 25129093
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
Shinkai M; Imano M; Chiba Y; Hiraki Y; Kato H; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
Anticancer Res; 2018 Oct; 38(10):5969-5974. PubMed ID: 30275227
[TBL] [Abstract][Full Text] [Related]
4. Conversion Surgery for Gastric Cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy.
Nakamura M; Ojima T; Nakamori M; Katsuda M; Tsuji T; Hayata K; Kato T; Yamaue H
J Gastrointest Surg; 2019 Sep; 23(9):1758-1766. PubMed ID: 30264385
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.
Fujitani K; Tsujinaka T; Hirao M
Hepatogastroenterology; 2003; 50(51):889-92. PubMed ID: 12828112
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
8. [S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
Shimoyama S; Kiyokawa T; Nishida M; Seto Y
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1411-4. PubMed ID: 22996780
[TBL] [Abstract][Full Text] [Related]
9. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
[TBL] [Abstract][Full Text] [Related]
10. [S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case].
Wakahara T; Toyokawa A; Tomono A; Tani S; Yamamichi T; Nishioka N; Gon H; Yamashita H; Nakajima T; Kanemitsu K; Takahashi T; Okuda T; Tanaka K; Tsukamoto T; Hamabe Y; Iwasaki T; Ishida T
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1361-4. PubMed ID: 20647727
[TBL] [Abstract][Full Text] [Related]
11. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
[TBL] [Abstract][Full Text] [Related]
12. [A case of advanced gastric cancer responding to S-1/paclitaxel was pathologically complete response].
Aoki T; Tanida T; Tsukao Y; Igarashi Y; Komori T; Matsumoto T; Takachi K; Nishioka K; Uemura Y; Kobayashi K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2045-7. PubMed ID: 19106518
[TBL] [Abstract][Full Text] [Related]
13. Unusual survival for more than 2 years with peritoneal metastases of gastric cancer.
Kobayashi O; Konishi K; Kanari M; Cho H; Yoshikawa T; Tsuburaya A; Sairenji M; Motohashi H
Gastric Cancer; 2002; 5(1):47-50. PubMed ID: 12021860
[TBL] [Abstract][Full Text] [Related]
14. [A case of scirrhous gastric carcinoma with peritoneal dissemination which was treated by curative gastrectomy after S-1/CDDP chemotherapy].
Akagi T; Etoh T; Eguchi H; Hiroishi K; Ueda Y; Yasuda K; Noguchi T; Shiraishi N; Kitano S
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1573-7. PubMed ID: 20716890
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Post-Gastrectomy Adjuvant S-1 Chemotherapy on Muscle Volume in Gastric Cancer Patients].
Iwazawa T; Kawanishi K; Fujita J; Takata A; Hirota M; Imamura H; Ikeda A; Hokonohara K; Yoneyama C; Kameyama A; Shinke G; Oshima K; Tanida T; Hatano H; Noda T; Komori T; Morita S; Akagi K; Dono K
Gan To Kagaku Ryoho; 2015 Aug; 42(8):957-60. PubMed ID: 26321709
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with S-1 and surgical resection for a mucinous gastric cancer with peritoneal dissemination.
Hamada M; Tsuji A; Iwata J; Nishioka Y; Ozaki K; Shima Y; Horimi T
Gastric Cancer; 2005; 8(1):50-4. PubMed ID: 15747176
[TBL] [Abstract][Full Text] [Related]
17. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.
Kano Y; Ohashi M; Hiki N; Takahari D; Chin K; Yamaguchi K; Tsuda Y; Shoji Y; Yasufuku I; Eto K; Ida S; Kumagai K; Nunobe S; Sano T
Gastric Cancer; 2018 Nov; 21(6):1024-1030. PubMed ID: 29700635
[TBL] [Abstract][Full Text] [Related]
18. [Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric Cancer].
Shinkai M; Imano M; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Kimura Y; Imamoto H; Furukawa H; Yasuda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1355-1357. PubMed ID: 29394632
[TBL] [Abstract][Full Text] [Related]
19. [A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
Ishii Y; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Matsumoto H; Yamaguchi T; Nakano D
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2084-6. PubMed ID: 22202291
[TBL] [Abstract][Full Text] [Related]
20. [TS-1 was prescribed for a patient with stomach cancer with peritoneal dissemination who survived for 3 years and 2 months].
Mikata S; Iwase K; Higaki J; Miyazaki M; Yoshikawa S; Ide H; Kim H; Oimatsu N; Inayama M; Kamiike W
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1225-7. PubMed ID: 15332548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
